Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06166745 · ClinicalTrials.gov registry record · NA

Efficacy of Sensi-IP Toothpaste in the Treatment of Dentinal Hypersensitivity Compared to a Sodium Fluoride Toothpaste

A NA study of Dentinal Hypersensitivity, sponsored by IR Scientific.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT06166745 is a NA study of Dentinal Hypersensitivity that has completed, run by IR Scientific. The registered enrollment target is 46 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06166745, a NA study of Dentinal Hypersensitivity, has completed, sponsored by IR Scientific.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

The study is designed as a prospective, randomized, parallel arm, double blinded, pilot clinical trial.The primary objective is to evaluate the efficacy of Sensi-IP +NaF as compared to a NaF toothpaste in the reduction of dentin hypersensitivity in adult participants over 14 days. Study endpoints include Evaporative Air blast Stimuli (Schiff Airblast Sensitivity Score), Tactile Stimuli (Yeaple probe Assessment), Visual Analogue Scale Evaporative Stimuli and the occurrence of adverse events. The study will include 2 study arms: 1. Sodium fluoride toothpaste with Sensi IP (N=23) and 2. Sodium fluoride toothpaste (N=23). Total of 46 participants (ages 18-80 years) with at least one hypersensitive tooth in 2 different quadrants which are anterior to the molars will be enrolled.

Conditions Studied

Interventions

  • DEVICE Sensi-IP toothpaste
  • DEVICE Sodium Fluoride Toothpaste

Study Locations (1)

Massachusetts

  • The Forsyth Institute - Cambridge

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2023-11-06
Est. Completion 2024-04-15
Phase NA

Sponsor

IR Scientific

1 total trials

What the Registry Record Tells You About NCT06166745

The ClinicalTrials.gov registry entry for NCT06166745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is IR Scientific, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dentinal Hypersensitivity appearing as the primary indexed condition, and to 2 interventions - of which Sensi-IP toothpaste is the first listed.

NCT06166745 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06166745 about?

NCT06166745 is a clinical study titled "Efficacy of Sensi-IP Toothpaste in the Treatment of Dentinal Hypersensitivity Compared to a Sodium Fluoride Toothpaste". The study is designed as a prospective, randomized, parallel arm, double blinded, pilot clinical trial.The primary objective is to evaluate the efficacy of Sensi-IP +NaF as compared to a NaF toothpaste in the reduction of dentin hypersensitivity in adult participants over 14 days. Study endpoints in...

What is the current status of trial NCT06166745?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2023-11-06. Estimated completion is 2024-04-15.

What conditions does trial NCT06166745 study?

This clinical trial studies the following conditions: Dentinal Hypersensitivity.

What interventions are being tested in trial NCT06166745?

The interventions under investigation include: Sensi-IP toothpaste (DEVICE), Sodium Fluoride Toothpaste (DEVICE).

Who is sponsoring clinical trial NCT06166745?

This trial is sponsored by IR Scientific, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06166745 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.